Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Multiple Sclerosis, Vol. 11, No. 3, 328-337 (2005)
DOI: 10.1191/1352458505ms1162oa
© 2005 SAGE Publications

The Goldman Consensus statement on depression in multiple sclerosis

Goldman Consensus Group

Background. In January 2002 the New York City Chapter of the National Multiple Sclerosis Society convened a panel of experts to review the issue of depressive affective disorders associated with multiple sclerosis (MS). This Consensus Conference was supported by a grant from the Goldman family of New York City. Results. The panel reviewed summaries of current epidemiologic, neurobiologic, and therapeutic studies having to do with depressive disorders among MS patient populations. Depressive disorders occur at high rates among patients with MS, and there is reason to believe that the immunopathology of the disease is involved in the clinical expression of affective disorders. The depressive syndromes of MS have a major, negative impact on quality of life for MS sufferers, but are treatable. At the present time, most MS patients with depression do not receive adequate recognition and treatment. Conclusions. The Goldman Consensus Conference Study Group provides recommendations for improved screening, diagnosis, and clinical management for depressive affective disorders among patients suffering from MS.

Key Words: affective disorders • cognition • depression • multiple sclerosis • neuropsychiatry


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Johansson, C Ytterberg, J Hillert, L W. Holmqvist, and L von Koch
A longitudinal study of variations in and predictors of fatigue in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 454 - 457.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Patten, J. Williams, and L. Metz
Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 406 - 411.
[Abstract] [PDF]


Home page
NeurologyHome page
S. L. Minden, D. C. Hoaglin, L. Hadden, D. Frankel, T. Robbins, and J. Perloff
Access to and utilization of neurologists by people with multiple sclerosis
Neurology, March 25, 2008; 70(13_Part_2): 1141 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
K. Cetin, K.L. Johnson, D.M. Ehde, C.M. Kuehn, D. Amtmann, and G.H. Kraft
Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample
Multiple Sclerosis, September 1, 2007; 13(8): 1046 - 1053.
[Abstract] [PDF]


Home page
Mult SclerHome page
D C Mohr, S L Hart, L Julian, and E S Tasch
Screening for depression among patients with multiple sclerosis: two questions may be enough
Multiple Sclerosis, March 1, 2007; 13(2): 215 - 219.
[Abstract] [PDF]


Home page
Palliat MedHome page
T Kumpfel, L A Hoffmann, W Pollmann, P Rieckmann, U K Zettl, R Kuhnbach, G D Borasio, and R Voltz
Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists
Palliative Medicine, March 1, 2007; 21(2): 109 - 114.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Gottberg, U Einarsson, S Fredrikson, L von Koch, and L W Holmqvist
A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence
J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 60 - 65.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
R. J. Buchanan, R. Schiffer, S. Wang, A. Stuifbergen, B. Chakravorty, L. Zhu, M. Suk Kim, and W. James
Satisfaction With Mental Health Care Among People With Multiple Sclerosis in Urban and Rural Areas
Psychiatr Serv, August 1, 2006; 57(8): 1206 - 1209.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
M. Schilling, C. Brueckner-Totonji, V. Arolt, and B. T. Baune
A Case of Multiple Sclerosis Masked by Depression and Diabetic Neuropathy
Psychosomatics, August 1, 2006; 47(4): 361 - 363.
[Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
K. Jefferies
The neuropsychiatry of multiple sclerosis
Advan. Psychiatr. Treat., May 1, 2006; 12(3): 214 - 220.
[Abstract] [Full Text] [PDF]